RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--To help biopharmaceutical and government organizations better understand how medicines are used and perform in “real world” settings, Quintiles today announced recent signings and commitments to multiple sources of data that will give it access to de-identified electronic medical records (EMR) data representing 40 million patient lives.
